showed a left TPT aneurysm extending to the bifurcation of the posterior tibial and peroneal arteries (Fig 2) . An open surgical repair was planned. A below-knee medial approach was taken, and further dissection revealed a TPT aneurysm involving the distal end of the TPT as well as the origin of the posterior tibial artery and peroneal artery. Arteriotomy of the aneurysm sac confirmed a thick-walled, true TPT aneurysm without thrombus. The ipsilateral great saphenous vein was then harvested, reversed, and used as an interposition bypass. The postoperative period was uncomplicated, and the patient was discharged on the same day. The patient's symptoms resolved postoperatively, and she remained asymptomatic at 3-month, 6-month, and 2-year follow-up visits.
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Early and Long-Term Outcomes of Open Versus Endovascular Repair Using Covered Stents for TASC C-D Aortoiliac Obstructive Lesions in Low-Risk and Young Patients*
Michele Piazza, Francesco Squizzato, Riccardo Bozza, Sandro Lepidi, Mirko Menegolo, Franco Grego, Michele Antonello. Padova University, Padova, Italy
Objective: The aim of this study was to compare open repair (OR) vs endovascular repair (ER) using covered stents for TransAtlantic Inter-Society Consensus (TASC) C and D aortoiliac obstructive lesions in patients at low surgical risk and in young patients.
Methods: A single-center retrospective review of TASC C and D iliac lesions treated between January 2008 and November 2017 was conducted. The 30-day outcomes, long-term patency, limb salvage, and freedom from related reintervention were compared between OR an ER. Low surgical risk was defined as Society for Vascular Surgery comorbidity score of 0.7 and age 75 years. A subanalysis was performed in patients considered young (age, 60 years). Follow-up results were analyzed with Kaplan-Meier curves. Major clinical and anatomic characteristics were evaluated for their association with patency in the two groups using Cox proportional hazards.
Results: Overall, 112 patients (OR, n ¼ 56; ER, n ¼ 56) were treated, with 63% having bilateral iliac disease involvement (n ¼ 70 patients) for a total of 182 limbs revascularized (OR, n ¼ 96; ER, n ¼ 86 Table) .
Conclusions: In case of severe aortoiliac obstructive lesions in lowrisk and young patients, ER using covered stent may be considered as valid as OR because it allows shorter hospitalization after the procedure, maintaining similar patency during long-term follow-up. However, in female patients, OR still remains the "gold standard" of treatment. Objective: Lower extremity amputation is commonly performed nationwide. Whereas previous studies have reported modest rates of acute reoperation for lower extremity amputations, data are scarce regarding the need for early reamputation to a higher anatomic level. The goal of this study was to better define contemporary outcomes and risk factors associated with reamputation.
Methods: Within the 2012 to 2016 American College of Surgeons National Surgical Quality Improvement Program database, patients who underwent primary major lower extremity amputation (below knee [BKA], above knee [AKA]) were identified by Current Procedural Terminology code. Patients undergoing concomitant procedures, those classified as American Society of Anesthesiologists class 5, and those without primary wound closure, including guillotine amputations, were excluded. Outcomes of patients undergoing early (within 30 days) reamputation to a higher anatomic level were compared with those of patients who did not, including length of stay, morbidity, and mortality. Demographic, clinical, and perioperative characteristics were compared, and those risk factors approaching significance were used in a multivariable logistic regression model to determine their association with early reamputation.
Results: There were 14,673 patients identified for the 5-year period: 8306 BKAs and 6367 AKAs. Most patients were male (63%), white (62%), and diabetic (63%), with a median age of 67 years (interquartile range, 58-77 years). Most major amputations were performed by vascular surgeons (65%). Overall, lower level amputations were associated with a higher reamputation rate (BKA, 2.5%; AKA, 0.8%; P < .001). Reamputation was associated with increased length of stay (8 days vs 5 days; P < .001) and greater rates of readmission (64.9% vs 13.6%; P < .001). Reamputation was associated with greater rates of wound complications (40.8% vs 6.9%; P < .001), myocardial infarction (3.8% vs 1.7%; P ¼ .027), pulmonary embolism (1.9% vs 0.4%; P ¼ .004), sepsis (20.2% vs 5.0%; P < .001), and complications overall (69.5% vs 39.3%; P < .001). The 30-day mortality was not significantly different for the two groups (4.2% vs 6.3%; P ¼ 0.159). On multivariable analysis, advanced age (odds ratio [OR] Conclusions: Based on this study, early reamputation rates are low. Reamputation is associated with significant morbidity, prolonged hospitalization, and frequent readmissions. Patient-specific factors and comorbidities should be considered in selecting the appropriate anatomic level of amputation. Further studies are needed, particularly by vascular surgeons, to elucidate this population of patients and to minimize the risk of reamputation.
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African Americans Are at Higher Risk for Limb Loss But Not Mortality After Lower Extremity Bypass Surgery Objective: Lower extremity revascularization is the "gold standard" for treatment of symptomatic peripheral arterial disease. The objective of this study was to examine the impact of race on outcomes among patients with peripheral arterial disease who have undergone open lower extremity bypass.
Methods: Data were obtained from the 2013 American College of Surgeons National Surgical Quality Improvement Program database using the procedure targeted Participant Use Data File. Patients were divided into three groups based on race: whites, African Americans, and Hispanic. Bivariate analysis was done for preoperative, intraoperative, and postoperative risk factors among races. Multivariate analysis was used to determine associations of independent variables with mortality and lower extremity amputation as primary outcomes.
Results: A total of 2381 patients (31.9% female, 68.1% male) were identified in the National Surgical Quality Improvement Program database who underwent lower extremity bypass in the year 2013. Among these patients, 1732 (72.74%) were white, 488 (20.50%) were African American, and 161 (6.76%) were Hispanic. African American patients were more likely to have undergone urgent surgery, to have hypertension, to be on dialysis, and to present with rest pain and tissue loss (P < .05). They were also more likely to return to the operating room and to be readmitted within 30 days (P ¼ .003). On multivariate analysis, the following factors were found to have significant association with amputation: African American race (vs white race: odds ratio [OR], 2.5; confidence interval [CI], 1.5-4; P < .05), length of total hospital stay 7 days (OR, 4; CI, 2.3-7.5; P < .05), return to operating room (OR, 9.4; CI, 5.3-16.6; P < .05), unplanned readmission within 30 days (OR, 1.9; CI ,1.2-3.098; P < .05), and major reintervention on the bypass (OR, 2; CI, 1.4-4.3; P < .05). Factors that have significant associations with mortality included age 60 to 69 years (vs <60 years: OR, 10; CI, 2.3-43.4; P < .05), age 70 to 79 years (vs <60 years: OR, 7.6; CI, 1.7-33.8; P < .05), age 80 years (vs <60 years: OR, 14; CI, 3.1-63.1; P < .05), dialysis (OR, 8.2; CI, 4.4-15.1; P < .05), length of total hospital stay 7 days (OR, 2.5; CI, 1.3-4.8; P < .05), and major reintervention on the bypass (OR, 3.4; CI, 1.5-7.9; P < .05).
Conclusions: African American patients were more likely than white and Hispanic patients to undergo major amputation after open lower extremity bypass. Unlike previously published data, this study does not show any difference in mortality.
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